Shandong Jincheng Pharmaceutical and Chemical Co Ltd Financial Flexibility Index
Shandong Jincheng Pharmaceutical and Chemical Co Ltd financial flexibility index. Shandong Jincheng Pharmaceutical and Chemical Co Ltd (300233) has a Financial Flexibility Index of 0.08x as of September 2025. Free cash flow of CN¥118.65 Million (operating CF CN¥79.81 Million minus capex CN¥38.83 Million) represents 0% of total liabilities (CN¥1.42 Billion). Explore 300233 capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Shandong Jincheng Pharmaceutical and Chemical Co Ltd (2008–2025)
Financial flexibility index of Shandong Jincheng Pharmaceutical and Chemical Co Ltd from 2008 to 2025. Historical Financial Flexibility Index trend for Shandong Jincheng Pharmaceutical and Chemical Co Ltd across 18 annual periods. Check Shandong Jincheng Pharmaceutical and Che cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Shandong Jincheng Pharmaceutical and Chemical Co Ltd Financial Flexibility Index by Year (2008–2025)
Shandong Jincheng Pharmaceutical and Chemical Co Ltd financial flexibility index by year from 2008 to 2025. Year-by-year free cash flow to debt coverage for Shandong Jincheng Pharmaceutical and Chemical Co Ltd. For the full cash flow conversion analysis, see cash efficiency ratio of Shandong Jincheng Pharmaceutical and Che.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.29x | CN¥420.52 Million | CN¥319.64 Million | CN¥1.47 Billion | ▲ +15.7% |
| 2024 | 0.25x | CN¥439.20 Million | CN¥296.59 Million | CN¥1.77 Billion | ▼ -47.5% |
| 2023 | 0.47x | CN¥1.01 Billion | CN¥664.08 Million | CN¥2.14 Billion | ▲ +62.4% |
| 2022 | 0.29x | CN¥629.29 Million | CN¥255.63 Million | CN¥2.17 Billion | ▼ -34.4% |
| 2021 | 0.44x | CN¥813.33 Million | CN¥437.19 Million | CN¥1.84 Billion | ▼ -17.0% |
| 2020 | 0.53x | CN¥818.56 Million | CN¥546.13 Million | CN¥1.53 Billion | ▼ -14.3% |
| 2019 | 0.62x | CN¥939.63 Million | CN¥577.98 Million | CN¥1.51 Billion | ▲ +6.4% |
| 2018 | 0.59x | CN¥702.08 Million | CN¥352.20 Million | CN¥1.20 Billion | ▲ +63.8% |
| 2017 | 0.36x | CN¥345.63 Million | CN¥151.83 Million | CN¥966.24 Million | ▼ -32.8% |
| 2016 | 0.53x | CN¥400.38 Million | CN¥241.48 Million | CN¥752.68 Million | ▼ -0.8% |
| 2015 | 0.54x | CN¥367.77 Million | CN¥207.92 Million | CN¥685.95 Million | ▼ -5.4% |
| 2014 | 0.57x | CN¥379.02 Million | CN¥219.46 Million | CN¥668.61 Million | ▲ +23.6% |
| 2013 | 0.46x | CN¥254.10 Million | CN¥93.92 Million | CN¥554.11 Million | ▲ +15.7% |
| 2012 | 0.40x | CN¥195.81 Million | CN¥86.61 Million | CN¥494.26 Million | ▼ -12.0% |
| 2011 | 0.45x | CN¥197.69 Million | CN¥62.69 Million | CN¥439.36 Million | ▲ +7.7% |
| 2010 | 0.42x | CN¥243.46 Million | CN¥108.67 Million | CN¥582.62 Million | ▼ -13.3% |
| 2009 | 0.48x | CN¥198.21 Million | CN¥105.62 Million | CN¥411.04 Million | ▲ +137.7% |
| 2008 | 0.20x | CN¥83.10 Million | CN¥30.23 Million | CN¥409.67 Million | — |